Thromboangiitis Obliterans Biomarker Shifts in Different Acute Phase Stages: A Case Study
Georg Amun Hofmann1, Bernhard Zierfuss2, Renate Koppensteiner2
1Division of Angiology, Department of Medicine 2, Medical University of Vienna, Vienna, Austria; Department of Dermatology, Disease Modeling and Organoid Technology (DMOT) Research Group, Medical University of Vienna, Vienna, Austria.
Abstract:
Thromboangiitis obliterans (TAO) is a rare vasculopathy that is predominantly seen in young male smokers. Recently, new biomarkers have been shown to be useful in distinguishing TAO from acute phase TAO in an Asian study population. The present case study illustrates their application in a European patient during TAO exacerbation and their association with therapeutic performance.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies


